Cargando…

FSTL1 promotes bone metastasis by causing immune dysfunction

In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail...

Descripción completa

Detalles Bibliográficos
Autor principal: Kudo-Saito, Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897500/
https://www.ncbi.nlm.nih.gov/pubmed/24482748
http://dx.doi.org/10.4161/onci.26528
_version_ 1782300243637829632
author Kudo-Saito, Chie
author_facet Kudo-Saito, Chie
author_sort Kudo-Saito, Chie
collection PubMed
description In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail family zinc finger 1 (SNAI1)-expressing cancer cells, as a key determinant of bone metastasis that operates by inducing a systemic state of immune dysfunction.
format Online
Article
Text
id pubmed-3897500
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38975002014-01-30 FSTL1 promotes bone metastasis by causing immune dysfunction Kudo-Saito, Chie Oncoimmunology Author's View In spite of significant advances in our understanding of the metastatic process, the relationship between the dissemination of primary neoplasms to the bones and antitumor immunity remains poorly understood. We have recently identified follistatin-like 1 (FSTL1), a soluble protein secreted by snail family zinc finger 1 (SNAI1)-expressing cancer cells, as a key determinant of bone metastasis that operates by inducing a systemic state of immune dysfunction. Landes Bioscience 2013-11-01 2013-10-10 /pmc/articles/PMC3897500/ /pubmed/24482748 http://dx.doi.org/10.4161/onci.26528 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Kudo-Saito, Chie
FSTL1 promotes bone metastasis by causing immune dysfunction
title FSTL1 promotes bone metastasis by causing immune dysfunction
title_full FSTL1 promotes bone metastasis by causing immune dysfunction
title_fullStr FSTL1 promotes bone metastasis by causing immune dysfunction
title_full_unstemmed FSTL1 promotes bone metastasis by causing immune dysfunction
title_short FSTL1 promotes bone metastasis by causing immune dysfunction
title_sort fstl1 promotes bone metastasis by causing immune dysfunction
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897500/
https://www.ncbi.nlm.nih.gov/pubmed/24482748
http://dx.doi.org/10.4161/onci.26528
work_keys_str_mv AT kudosaitochie fstl1promotesbonemetastasisbycausingimmunedysfunction